Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Drug Discovery Today. Technologies|July 21, 2015
Nuclear magnetic resonance: a key metabolomics platform in the drug discovery processJustine Leenders, Michel Frédérich, Pascal de Tullio
The AAPS Journal|August 26, 2015
2D-Cosy NMR Spectroscopy as a Quantitative Tool in Biological Matrix: Application to CyclodextrinsGilles Dufour, Brigitte Evrard, Pascal de Tullio
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 24, 2015
Rapid quantification of 2-hydroxypropyl-β-cyclodextrin in liquid pharmaceutical formulations by (1)H nuclear magnetic resonance spectroscopyGilles Dufour, Brigitte Evrard, Pascal de Tullio
Bioorganic & Medicinal Chemistry|February 4, 2006
Synthesis and pharmacological evaluation of some N-arylsulfonyl-N-methyl-N'-(2,2-dimethyl-2H-1-benzopyran-4-yl)ureas structurally related to cromakalimSmail Khelili, Philippe Lebrun, Pascal de Tullio, et al.
Pharmaceuticals (Basel, Switzerland)|December 7, 2017
31ièmes Journées Franco-Belges de Pharmacochimie: Meeting ReportRaphaël Frédérick, Lionel Pochet, Pascal De Tullio, et al.
Journal of Medicinal Chemistry|June 14, 2016
Metabolomics as a Challenging Approach for Medicinal Chemistry and Personalized MedicineMichel Frédérich, Bernard Pirotte, Marianne Fillet, et al.
Frontiers in Molecular Biosciences|October 7, 2021
Nuclear Magnetic Resonance Spectroscopy in Clinical Metabolomics and Personalized Medicine: Current Challenges and PerspectivesMarine P M Letertre, Patrick Giraudeau, Pascal de Tullio
Expert Opinion on Therapeutic Patents|February 15, 2013
AMPA receptor positive allosteric modulators: a patent reviewBernard Pirotte, Pierre Francotte, Eric Goffin, et al.
Bioorganic & Medicinal Chemistry|June 14, 2011
Modulation of the 6-position of benzopyran derivatives and inhibitory effects on the insulin releasing processXavier Florence, Sébastien Dilly, Pascal de Tullio, et al.
Pageof 10